Avadomide
Avadomide is an orally active cereblon modulator. Avadomide modulates cereblon E3 ligase activity, inhibits NF-κB pathway, arrests the cell cycle at G1 phase, and thus induces apoptosis in cancer cell PDAC. Avadomide exhibits potent antitumor and immunomodulatory activities[1][2][3].
Product Specifications
CAS Number
1015474-32-4
Product Name Alternative
CC 122
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; E1/E2/E3 Enzyme; Molecular Glues; NF-κB
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease; NF-κB; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CC122.html
Purity
99.56
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
O=C(C(N1C(C)=NC2=C(C(N)=CC=C2)C1=O)CC3)NC3=O
Molecular Formula
C14H14N4O3
Molecular Weight
286.29
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bovine Cytochrome P450 2E1,CYP2E1 ELISA KIT
Bovine Cytochrome P450 2E1,CYP2E1 ELISA KIT
Lentiviral human GSTM3 shRNA (UAS) - Lentiviral human GSTM3 shRNA (UAS, iRFP) (100)
